Paul Martin

56.8k citations
579 papers · 42.3k indexed · 14 hit papers · h-index 95

Impact in

  • Hepatology top 0.02%
    • Hepatitis C virus research
    • Liver Disease and Transplantation
  • Rehabilitation top 0.01%
    • Wound Healing and Treatments

Papers in

    • Hepatitis C virus research 236
    • Liver Disease and Transplantation 110
    • Renal Transplantation Outcomes and Treatments 40

Paul Martin

563 papers receiving 41.1k citations

Hit Papers

Cellular and molecular mechanisms of skin wound healing 2024 · 638 citations
638199420262004201510002.0k3.0k

Peers

Paul Martin
Comparison fields: 5 of 224
  • Hepatology 12.5k
  • Rehabilitation 8.3k
  • Transplantation 1.4k
  • Epidemiology 11.9k
  • Cell Biology 4.9k
Replace Irving L. Weissman with:
Irving L. Weissman United States
Shizuo Akira Japan
Darwin J. Prockop United States
Kenneth J. Livak United States
Richard A. Flavell United States
Zena Werb United States
Joan Massagué United States
Thomas A. Wynn United States
Alberto Mantovani Italy
Michael T. Longaker United States
Paul Martin relative to Irving L. Weissman United States Irving L. Weissman's profile →
Citations per field
00.5×8.1×
Irving L. Weissman · 1×
Citations per year

Countries citing papers authored by Paul Martin

Since Specialization
Citations

This map shows the geographic impact of Paul Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Martin more than expected).

Fields of papers citing papers by Paul Martin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Martin. The network helps show where Paul Martin may publish in the future.

Co-authors

The 25 scholars most cited alongside Paul Martin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Paul Martin Line = papers co-authored together Paul Martin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20244
2 20241
3 20234
4 20238
5 201929
6 2015219
7 20149
8 201280
9 201096
10 2008151
11 200846
12
Dynamic analysis of filopodial interactions during the zippering phase of Drosophila dorsal closure
20089
13 20086
14 200685
15 200673
16 200589
17
Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B 1 1The Adefovir Dipivoxil International 461 Study Group includes the following: N. Afdhal (Beth Israel Deaconess Medical Center, Boston, MA); P. Angus (Austin and Repatriation Medical Centre, Melbourne, Australia); Y. Benhamou (Hopital La Pitie Salpetriere, Paris, France); M. Bourliere (Hopital Saint Joseph, Marseille, France); P. Buggisch (Universitaetsklinikum Eppendorf, Department of Medicine, Hamburg, Germany); P. Couzigou (Hopital Haut Leveque, Pessac, France); P. Ducrotte and G. Riachi (Hopital Charles Nicolle, Rouen, France); E. Jenny Heathcote (Toronto Western Hospital, Toronto, Ontario, Canada); H. W. Hann (Jefferson Medical College, Philadelphia, PA); I. Jacobson (New York Presbyterian Hospital, New York, NY); K. Kowdley (University of Washington Hepatology Center, Seattle, WA); P. Marcellin (Hopital Beaujon, Clichy, France); P. Martin (Cedars-Sinai Medical Center, Los Angeles, CA); J. M. Metreau (Centre Hospitalier Universitaire Henri Mondor, Creteil, France); M. G. Peters (University of California, San Francisco, San Francisco, CA); R. Rubin (Piedmont Hospital, Atlanta, GA); S. Sacks (Viridae Clinical Sciences, Inc., Vancouver, Canada); H. Thomas (St. Mary’s Hospital, London, England); C. Trepo (Hopital Hôtel Dieu, Lyon, France); D. Vetter (Hopital Civil, Strasbourg, France); C. L. Brosgart, R. Ebrahimi, J. Fry, C. Gibbs, K. Kleber, J. Rooney, M. Sullivan, P. Vig, C. Westland, M. Wulfsohn, and S. Xiong (Gilead Sciences, Inc., Foster City, CA); D. F. Gray (GlaxoSmithKline, Greenford, Middlesex, England); R. Schilling and V. Ferry (Parexel International, Waltham, MA); and D. Hunt (Covance Laboratories, Princeton, NJ).
2003440
18 199623
19
La medición del comportamiento
199123
20 1990110

About Paul Martin

Paul Martin is a scholar working on Hepatology, Transplantation, Epidemiology, Rehabilitation and Cell Biology, having authored 579 papers that have together received 42.3k indexed citations. Recurring topics across this work include Hepatitis C virus research (236 papers), Liver Disease Diagnosis and Treatment (201 papers), Hepatitis B Virus Studies (175 papers), Liver Disease and Transplantation (110 papers), Organ Transplantation Techniques and Outcomes (71 papers), Wound Healing and Treatments (50 papers), Renal Transplantation Outcomes and Treatments (40 papers) and Cellular Mechanics and Interactions (39 papers). The work is most often cited by research in Hepatology (12.5k citations), Rehabilitation (8.3k citations), Transplantation (1.4k citations), Epidemiology (11.9k citations) and Cell Biology (4.9k citations). Paul Martin has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Sabine A. Eming, Marjana Tomic‐Canic, Will Wood, Fabrizio Fabrizi, Tanya J. Shaw, Robert Nunan, S. Joseph Leibovich, Piergiorgio Messa, F. Fabrizi and António Jacinto. Their work appears in journals such as Alimentary Pharmacology & Therapeutics, Current Biology, Hepatology, Clinics in Liver Disease and Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026